0001958314-22-000002.txt : 20221215 0001958314-22-000002.hdr.sgml : 20221215 20221215172151 ACCESSION NUMBER: 0001958314-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 EFFECTIVENESS DATE: 20221215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HB Biotech, Inc. CENTRAL INDEX KEY: 0001958314 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-467639 FILM NUMBER: 221465724 BUSINESS ADDRESS: STREET 1: 515 WEST 20TH STREET STREET 2: SUITE 4E CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 2126477777 MAIL ADDRESS: STREET 1: 515 WEST 20TH STREET STREET 2: SUITE 4E CITY: NEW YORK STATE: NY ZIP: 10011 D 1 primary_doc.xml X0708 D LIVE 0001958314 HB Biotech, Inc. 515 WEST 20TH STREET SUITE 4E NEW YORK NY NEW YORK 10011 2126477777 DELAWARE None None Corporation true 2022 Tomer Seifan 515 West 20th Street Suite 4E New York NY NEW YORK 10011 Executive Officer Director Chief Executive Officer Other Decline to Disclose 06b false 2022-12-01 false true false 0 11000000 7795408 3204592 The issuer sold an aggregate of 58,467 shares of common stock at $133.33 per share to certain accredited investors. false 17 0 0 0 false HB Biotech, Inc. /s/ Tomer Seifan Tomer Seifan Director 2022-12-15